DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
85 hedge funds and large institutions have $565M invested in Dicerna Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
50% less funds holding in top 10
Funds holding in top 10: 8 → 4 (-4)
100% less call options, than puts
Call options by funds: $4K | Put options by funds: $1.53M
Holders
85
Holding in Top 10
4
Calls
$4K
Puts
$1.53M
Top Buyers
| 1 | +$28.5M | |
| 2 | +$24.5M | |
| 3 | +$18.9M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$8.88M |
| 5 |
State Street
Boston,
Massachusetts
|
+$8.78M |
Top Sellers
| 1 | -$22.1M | |
| 2 | -$9.56M | |
| 3 | -$4.09M | |
| 4 |
Millennium Management
New York
|
-$4.03M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$3.55M |